help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuma, K.
Right arrow Articles by Honda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuma, K.
Right arrow Articles by Honda, Y.
(American Journal of Pathology. 1999;154:343-354.)
© 1999 American Society for Investigative Pathology


Regular Articles

Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization

Kiyoshi Suzuma, Hitoshi Takagi, Atsushi Otani, Hideyasu Oh and Yoshihito Honda

From the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan

Thrombospondin-1 is an extracellular matrix protein that inhibits endothelial cell proliferation, migration, and angiogenesis. This study was performed to investigate the role of thrombospondin-1 in ischemic retinal neovascularization. In a murine model of retinal neovascularization, thrombospondin-1 mRNA was increased from postnatal day 13 (P13), with a threefold peak response observed on P15, corresponding to the time of development of retinal neovascularization. Prominent expression of thrombospondin-1 was observed in neovascular cells, specifically, cells adjacent to the area of nonperfusion. It has been suggested that vascular endothelial growth factor (VEGF) plays a major role in ischemia-induced retinal neovascularization of this model, so we studied the effects of VEGF on thrombospondin-1 expression. In bovine retinal microcapillary endothelial cells, VEGF induced a biphasic response of thrombospondin-1 expression; VEGF decreased thrombospondin-1 mRNA 0.41-fold after 4 hours, whereas it increased, with a threefold peak response, after 24 hours. VEGF-induced endothelial cell proliferation was completely inhibited by exogenous thrombospondin-1 and increased by 37.5% with anti-thrombospondin-1 antibody. The present findings suggest that, in the ischemic retina, retinal neovascular cells increase thrombospondin-1 expression, and VEGF may stimulate endogenous thrombospondin-1 induction, which inhibits endothelial cell growth. VEGF-mediated thrombospondin-1 induction in ischemia-induced angiogenesis may be a negative feedback mechanism.





This article has been cited by other articles:


Home page
IOVSHome page
T. F. Ng, B. Turpie, and S. Masli
Thrombospondin-1-Mediated Regulation of Microglia Activation after Retinal Injury
Invest. Ophthalmol. Vis. Sci., November 1, 2009; 50(11): 5472 - 5478.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Yamaji, S. Yoshida, K. Ishikawa, A. Sengoku, K. Sato, A. Yoshida, R. Kuwahara, K. Ohuchida, E. Oki, H. Enaida, et al.
TEM7 (PLXDC1) in Neovascular Endothelial Cells of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3151 - 3157.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. E. Markkanen, T. T. Rissanen, A. Kivela, and S. Yla-Herttuala
Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart-gene therapy
Cardiovasc Res, February 15, 2005; 65(3): 656 - 664.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Cursiefen, S. Masli, T. F. Ng, M. R. Dana, P. Bornstein, J. Lawler, and J. W. Streilein
Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris Angiogenesis
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1117 - 1124.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Sennlaub, F. Valamanesh, A. Vazquez-Tello, A.M. El-Asrar, D. Checchin, S. Brault, F. Gobeil, M.H. Beauchamp, B. Mwaikambo, Y. Courtois, et al.
Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy
Circulation, July 15, 2003; 108(2): 198 - 204.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T.-n. Lin, G.-M. Kim, J.-J. Chen, W.-M. Cheung, Y. Y. He, and C. Y. Hsu
Differential Regulation of Thrombospondin-1 and Thrombospondin-2 After Focal Cerebral Ischemia/Reperfusion
Stroke, January 1, 2003; 34(1): 177 - 186.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis
Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Chandrasekaran, C.-Z. He, H. Al-Barazi, H. C. Krutzsch, M. L. Iruela-Arispe, and D. D. Roberts
Cell Contact-dependent Activation of alpha 3beta 1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1
Mol. Biol. Cell, September 1, 2000; 11(9): 2885 - 2900.
[Abstract] [Full Text]


Home page
IOVSHome page
A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake
Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1
Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.